MedTrace Logo

Gabapentin And Breast Surgery Decision Architecture Randomization Trial (GABS-DART) Protocol

NCT07308717 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 1896

Last updated 2025-12-30

No results posted yet for this study

Summary

This study aims to assess whether gabapentin should be a standard component of peri-operative pain control in mastectomy patients at Memorial Sloan Kettering Cancer Center.

Conditions

Interventions

OTHER

Modification to Pre-operative Order Set

Modification to the pre-operative order set to remove gabapentin

Sponsors & Collaborators

Principal Investigators

  • James Flory, MD · Memorial Sloan Kettering Cancer Center

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-12-16
Primary Completion
2027-12-16
Completion
2027-12-16

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07308717 on ClinicalTrials.gov